Fortis Malar Hospitals Ltd
The short version
A shrinking, thinly profitable business — priced richly for what it earns.
What Fortis Malar Hospitals does
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of setting up, managing, and operating a multi-speciality hospital.
Worked out from Fortis Malar Hospitals's own filed results and exchange data, in plain words. Where a finance term matters, we say what it means.
01What does it do?
Fortis Malar Hospitals is a micro-sized company in hospitals.
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of setting up, managing, and operating a multi-speciality hospital.
- Whole company is worth
- ₹75 crore
- Shareholders
- 25,042 people
- Listed since
- 1993
A very small company by stock-market value — prices can swing hard and trading can be thin.
02Is it growing?
Sales have shrunk 76% a year for 5 years.
03Does it make money?
It earns ₹0 a year on every ₹100 its owners have invested.
On the money its owners have put in
It earns ₹0 a year on every ₹100 its owners have invested.
That figure is called return on equity (ROE). Under ₹12 is a thin return for the risk of owning shares. For comparison, a bank fixed deposit pays roughly ₹6–7.
Does the profit turn into cash?
For every ₹100 of profit it reported, ₹-10 actually came in as cash.
Over the last 3 years: ₹50 crore of profit but only −₹5.1 crore of cash. A wide gap like this is worth understanding before trusting the profit figure.
04Is the price high or low?
You pay ₹644 for every ₹1 of profit it makes in a year.
This is the P/E ratio: share price divided by a year's profit per share. A P/E of 644 means buyers are paying for about 644 years of today's profit up front.
The share price over the past year
It is 39% below its highest price of the past year and 4% above its lowest.
05Who owns it?
Its founders and parent group own 63 of every 100 shares — they control the company.
If the company were split into 100 equal shares, this is who would hold them. 25,042 people and institutions hold its shares.
As filed for the quarter ending 30 Sept 2026. Arrows show the change since the quarter before, in percentage points.
06What is going well, and what to watch
One thing going well, four things worth watching.
Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.
Going well
- Has almost no debt — it is not at the mercy of lenders.
Worth watching
- Sales have been shrinking — 76% a year.
- The share price is 644 times a year's profit, so it leans heavily on growth continuing.
- Thinly traded — only about ₹3 lakh of shares change hands a day, so buying or selling can move the price.
- The share price is 39% below its high of the past year.
07What happened lately?
Latest quarter: sales down 100%, profit down 96%.
Apr–Jun 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.
Sales
₹0.0 Cr
▼ 100.0% on a year earlier
Profit
₹0.1 Cr
▼ 96.4% on a year earlier
No notable developments in the last few weeks.
Advanced view
Every number, every table, the full chart.
Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.
Ask DoXy
Still have a question about Fortis Malar Hospitals?
This page describes Fortis Malar Hospitals using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.
Fortis Malar Hospitals Ltd (FORTISMLR): company summary
The company's business has improved significantly, with annual net profit rising 961.5% to ₹4 crore, though the latest quarter shows a sharp decline in net profit, falling 96.4% to ₹0 crore compared to the same quarter a year earlier.
Fortis Malar Hospitals Ltd (FORTISMLR) is a micro-cap Healthcare Services company valued at ₹75 crore operating in Hospitals on the NSE and BSE.
- Recent price move
- Fortis Malar Hospitals Ltd last traded at ₹40.5, modestly up 0.37% on the day.
- Financial performance
- The company's business has improved significantly, with annual net profit rising 961.5% to ₹4 crore, though the latest quarter shows a sharp decline in net profit, falling 96.4% to ₹0 crore compared to the same quarter a year earlier. Revenue remains at ₹0 crore for both the latest quarter and the full fiscal year, with a steep decline of -91.7% over three years.
- Valuation multiples
- The stock trades at 644.1 times earnings, 2.46 times book value.
- Things to watch
- The company's latest quarter net profit fell 96.4% to ₹0 crore, and the latest quarter revenue declined 100.0% to ₹0 crore. The stock is 38.9% below its 52-week high, and the company's return on equity is 0.0%, indicating no profitability in relation to shareholders' equity.
- Where it stands
- The company's net profit surged 961.5% annually to ₹4 crore, but the latest quarter shows a significant drop in net profit to ₹0 crore. The stock is 38.9% below its 52-week high, and the company remains unprofitable in the latest quarter.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
More Healthcare Services stocks · Hospitals
Explore Fortis Malar Hospitals Ltd’s valuation
Free deep-dive tools · no sign-up
Fortis Malar Hospitals Ltd peers in Healthcare Services
Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.
Related tools & concepts
Value Fortis Malar Hospitals Ltd with the ratios and calculators DocStoX uses in its analysis.

